Golden Green’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.89M Buy
3,510
+8
+0.2% +$4.12K 1.94% 15
2023
Q2
$1.64M Buy
+3,502
New +$1.47M 1.78% 17
2023
Q1
Sell
-2,440
Closed -$893K 85
2022
Q4
$893K Buy
2,440
+1,779
+269% +$631K 0.92% 32
2022
Q3
$214K Sell
661
-52
-7% -$16.5K 0.23% 66
2022
Q2
$231K Buy
+713
New +$214K 0.24% 54
2022
Q1
Sell
-2,023
Closed -$559K 103
2021
Q4
$559K Buy
2,023
+442
+28% +$112K 0.45% 61
2021
Q3
$365K Sell
1,581
-45
-3% -$11.1K 0.28% 90
2021
Q2
$373K Buy
1,626
+7
+0.4% +$1.41K 0.29% 107
2021
Q1
$302K Sell
1,619
-2,506
-61% -$490K 0.26% 127
2020
Q4
$696K Buy
+4,125
New +$616K 0.65% 46

Other funds holding LLY

Golden Green's LLY Position: Q3 2023 in Review

Golden Green increased its Eli Lilly (LLY) stake by 0.23% in Q3 2023, buying an estimated $4.12K and bringing the position to 3,510 shares worth $1.89M. The position accounts for 1.94% of the portfolio, ranked #15.

Golden Green first reported a position in LLY in Q4 2020 and has held it in 10 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Golden Green held 3,510 shares of Eli Lilly worth $1.89M as of Q3 2023.
  • Golden Green bought 8 Eli Lilly shares in Q3 2023, an estimated $4.12K.
  • Eli Lilly made up 1.94% of Golden Green's portfolio in Q3 2023, its #15 holding.
  • Golden Green first reported a position in Eli Lilly in Q4 2020 and has held it in 10 quarters since.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Golden Green's 13F filing for Q3 2023, filed 31 Oct 2023.